Oslo,

 Norway

Chief Executive Officer & Chairman:  Mr. Morrell is a Partner of Teknoivest AS. Prior to joining Teknoinvest, Mr. Morrell was the Managing Director for 2 years of a Teknoinvest portfolio company, Aquasmart International AS (after a merger now called AKVA group ASA). AKVA group is the leading technology and equipment provider to the global aquacultrure business. He has held numerous positions over the previous fourteen years including Managing Director for Merck & Co., Inc.'s subsidiary in Russia, Central Asia and the Caucuses; General Director of Veropham Co., Ltd (Russia); President of Hafslund Nycomed Pharma AG (Austria) and management consultant in McKinsey & Co., Inc. (Scandinavia). He also served in the U.S. Air Force as an officer and an F-15 fighter pilot (Japan). He currently serves as Chairman of the Board of Akva group ASA (Norway) and CiDRA Corporation (USA); Member of the Board of QuNano AB (Sweden) and Isolagen, Inc. (USA); and Observer to the Board of Verax Biomedical, Inc. (USA).

 Portland,

 Maine  USA

Co-Founder, President, and Chief Scientific Officer: In partnership with research scientists Steve Hebert, M.D., and Edward Brown, M.D., William Harris founded MariCal (originally AquaBio Products Sciences) in 1996.  Dr. Harris' research on mammals led to new insights as to a more fundamental and expanded role for calcium receptor proteins (CaSRs) other than sensing specific ions such as calcium.  Further research uncovered the roles of CaSRs as salinity nutrient sensors not only in fish and other aquatic organisms but also terrestrial animals.

In his early career, Dr. Harris was a faculty member and staff physician at The Children's Hospital in Boston, Massachusetts, USA and Harvard Medical School.  His research experience includes intervals at the Laboratory for Kidney and Electrolyte Metabolism at the National Institutes of Heath in Bethesda, Maryland, USA; Mount Desert Island Marine Biological Lab, Salisbury Cove, Maine, USA; Maine Medical Center Research Institute Portland, Maine, USA and Renal Research Laboratories at The Children's Hospital, Boston, MA USA.

Dr. Harris is internationally recognized as an expert on epithelial cell biology and body water metabolism, and as such has served on many international committees, authored over 150 publications and is co-inventor on 18 issued patents.   He has been a featured speaker at multiple international meetings focused on biotechnology, marine biology and aquaculture.  He holds a Ph.D. in Biochemistry from Harvard University and a M.D. magna cum laude from Harvard Medical School.  Additionally, Dr. Harris serves on the MariCal Board of Directors.

 Portland,

 Maine  USA

Chief Operating Officer :  Mr. Thomas has had a successful business career focusing on the execution of technology based businesses and marketing strategies, managing new and existing market development, establishing OEM and licensing partner relationships, and identifying and negotiating technology and product acquisitions in domestic and international markets.

Prior to joining MariCal, Mr. Thomas was president of Strategic Business Development, Inc., a life science consulting firm providing business development and strategy implementation consulting services to research, pharmaceutical, and biotechnology companies.

From 1996 to 1998 , Mr. Thomas was president and CEO of Biotherm International, Inc., an agrichemical company.  At Biotherm, Mr. Thomas Led the research and development planning process resulting in a novel biopesticide technology.  Additionally, Mr. Thomas coordinated equity and debt financing with the domestic and international financing and venture capital community.

Before Biotherm, Mr. Thomas was Director of Sales for the Food & Environmental Division of IDEXX Laboratories from 1992 to 1996.  During his tenure he established and led the newly created division to a dominant market position through establishing and managing North American, South American, and European marketing, sales, and business organization.

Prior to IDEXX Laboratories, Mr. Thomas was in marketing and sales management with the Agvet Division of Merck & Co., Inc.  While there he managed a number of leading veterinary pharmaceuticals including Ivermectin, the highest revenue generating veterinary product of all time.

Mr. Thomas received his Masters in Business Administration from California Polytechnic State University – San Luis Obispo in 1987 and a B. S. in Genetics from the University of California at Davis in 1984.

 Portland,

 Maine  USA

 Portland,

 Maine  USA

Senior Vice President, Research:  Dr. Betka is an expert in fish endocrinology and immunocytochemistry.  She is responsible for managing MariCal’s research lab and leading the efforts of the scientific staff.   Dr. Betka joined the company in 1999 as a Research Scientist, and has been a key leader in the research and development of SuperSmolt® and other MariCal technologies.  Prior to joining MariCal, she was a Research Associate in the Department of Biology at Boston University.  Dr. Betka holds a Ph.D. in biology from the University of Hannover, Germany.

 Puerto Montt

 Chile